Oral Remimazolam With and Without Alcohol in Healthy Female Subjects
Status:
Completed
Trial end date:
2017-08-09
Target enrollment:
Participant gender:
Summary
A Phase 1 Study to Determine the Single-dose Pharmacodynamics, Pharmacokinetics, and Safety
and Tolerability of Remimazolam Following Oral Administration With and Without Alcohol in
Healthy Female Subjects